This list is an analysis based on recent market events. It's not an investment recommendation.
About
Quia Pharma AB (publ) engages in the research, development, and commercialization of medicines based on Uni-Qleaver, a drug delivery platform. The company develops drugs through its pegylation technology platform. Its product pipeline includes QPG-1030 (pegylated teduglutide) for the treatment of short bowel syndrome, and QPG-1029 under pre-clinical development for stable plasma concentration, as well as antibody-drug conjugates being developed using the company's Uni-Qleaver technology-platform. The company was formerly known as QuiaPEG Pharmaceuticals Holding AB (publ) and changed its name to Quia Pharma AB (publ). Quia Pharma AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.
Show more...
CEO
Dr. Vidar Wendel-Hansen M.D., Ph.D.
Employees
2
Country
Sweden
ISIN
SE0001384850
Listings
0 Comments
Share your thoughts
FAQ
What is QuiaPEG Pharmaceuticals AB stock price today?▼
The current price of QUIA.ST is SEK0 SEK — it has decreased by -16.67% in the past 24 hours. Watch QuiaPEG Pharmaceuticals AB stock price performance more closely on the chart.
What is QuiaPEG Pharmaceuticals AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange QuiaPEG Pharmaceuticals AB stocks are traded under the ticker QUIA.ST.
Is QuiaPEG Pharmaceuticals AB stock price growing?▼
QUIA.ST stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year QuiaPEG Pharmaceuticals AB has showed a -96.24% decrease.
What is QuiaPEG Pharmaceuticals AB market cap?▼
Today QuiaPEG Pharmaceuticals AB has the market capitalization of 982,641.5
What is QuiaPEG Pharmaceuticals AB revenue for the last year?▼
QuiaPEG Pharmaceuticals AB revenue for the last year amounts to 0 SEK.
What is QuiaPEG Pharmaceuticals AB net income for the last year?▼
QUIA.ST net income for the last year is -66.76M SEK.
Does QuiaPEG Pharmaceuticals AB pay dividends?▼
Yes, QUIA.ST dividends are paid annual. The last dividend per share was 9.78 SEK. As of today, Dividend Yield (FWD)% is 0%.
How many employees does QuiaPEG Pharmaceuticals AB have?▼
As of April 17, 2026, the company has 2 employees.
In which sector is QuiaPEG Pharmaceuticals AB located?▼
QuiaPEG Pharmaceuticals AB operates in the Health & Wellness sector.
When did QuiaPEG Pharmaceuticals AB complete a stock split?▼
The last stock split for QuiaPEG Pharmaceuticals AB was on August 18, 2023 with a ratio of 2:1.
Where is QuiaPEG Pharmaceuticals AB headquartered?▼
QuiaPEG Pharmaceuticals AB is headquartered in Uppsala, Sweden.